The startups are the fourth and fifth drugmakers to file for initial public offerings since late December — the most notable ...

Sionna Therapeutics (SION), which is developing drugs to treat cystic fibrosis, has filed to raise $100M through an initial public offering. While Sionna (SION) didn't disclose terms in its SEC filing ...

Ascentage is looking to use the IPO proceeds to advance its Phase III candidates for chronic or small lymphocytic leukemia ...

IPO activity seems to have picked up in the U.S. with investors expecting the new Trump government to further its ...